About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Not Yet RecruitingPhase 2

SCALp Cooling for pReventing aLopecia With nEw anTibody-drug Conjugates

NCT07474558•Jules Bordet Institute

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Advanced or Metastatic Solid TumourAntibody-Drug ConjugateAlopecia

Interventions

scalp cooling

photographs via the Belle.AI app

+1 more

Locations

2

Belgium

Locations (2)

Institut Jules Bordet

Anderlecht, Brussels Capital, Belgium

CHU UCL Namur Site Sainte Elisabeth

Namur, Belgium

Key Dates

Start Date

September 1, 2026

Primary Completion Date

January 1, 2030

Completion Date

September 1, 2031

Last Updated

March 16, 2026

Related Studies

RECRUITINGPhase 3

Androgenic Alopecia TH07 Clinical Trial

NCT07435012

Androgenic Alopecia

RECRUITINGPhase 1/2

A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of ALD-102 Solution in Subjects With Alopecia Areata

NCT06826196

Alopecia Areata (AA)

Autologous Hair Follicle Secretome for Androgenic Alopecia (Single Site)

NCT07107841

Androgenic AlopeciaAlopecia+1 more

CorEvitas International Adolescent Alopecia Areata (AA) Drug Safety and Effectiveness Registry

NCT06562270

Alopecia Areata

RECRUITINGPhase 3

Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata

NCT07133308

Alopecia Areata

Combined Microneedling With Either 1% Lactic Acid Solution or Vitamin D3 or Triamcinolone Acetonide in The Treatment of Alopecia Areata

NCT06327581

Alopecia Areata

View all related studies

Contacts

Evandro de Azambuja Medical oncologist, Study Chair, MD PhD

CONTACT

+32 2 541 7244 evandro.deazambuja@hubruxelles.be

Sponsors

Lead Sponsor

Jules Bordet Institute

Collaborators

BelleTorus Corporation
Gilead Sciences
Paxman

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 16, 2026Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions